Drugs / nonoxynol-9 (N-9)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00274261 Comparator | Jun 2004 → Jul 2008 | pregnancy disorder | Premier Research | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nonoxynol-9 (N-9) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00274261 ↗ |
| Known as | Conceptrol | “Conceptrol® vaginal gel (nonoxynol-9)” NCT00274261 ↗ |
| Known as | N-9 | “nonoxynol-9 (N-9)” NCT00274261 ↗ |
| Route | Other | “The subject will insert one applicator of Conceptrol® vaginal gel (nonoxynol-9) prior to each episode of vaginal intercourse during her participation in the study.” NCT00274261 ↗ |